Written for drug developers rather than computer scientists, this monograph adopts a systematic approach to mining scientifi c data sources, covering all key steps in rational drug discovery, from compound screening to lead compound selection and personalized medicine. Clearly divided into four sections, the first part discusses the different data sources available, both commercial and non-commercial, while the next section looks at the role and value of data mining in drug discovery. The third part compares the most common applications and strategies for polypharmacology, where data mining can substantially enhance the research effort. The final section of the book is devoted to systems biology approaches for compound testing.
Throughout the book, industrial and academic drug discovery strategies are addressed, with contributors coming from both areas, enabling an informed decision on when and which data mining tools to use for one's own drug discovery project.
Remy Hoffmann studied Pharmacy at the University Louis Pasteur in Strasbourg (France). He then graduated in Medicinal Chemistry under Prof. C. G. Wermuth. After joining BioCAD in 1992 as a support scientist for the pharmacophore perception tool CATALYST in Europe, Dr. Hoffmann joined the new company Accelrys. Dr Hoffman's main areas of interest are in lead finding (screening, pharmacophore perception) and lead optimisation (QSAR).